Literature DB >> 12147351

Identification of a region in alcohol dehydrogenase that binds to alpha-crystallin during chaperone action.

Puttur Santhoshkumar1, Krishna K Sharma.   

Abstract

alpha-Crystallin, the major eye lens protein and a member of the small heat-shock protein family, has been shown to protect the aggregation of several proteins and enzymes under denaturing conditions. The region(s) in the denaturing proteins that interact with alpha-crystallin during chaperone action has not been identified. Determination of these sites would explain the wide chaperoning action (promiscuity) of alpha-crystallin. In the present study, using two different methods, we have identified a sequence in yeast alcohol dehydrogenase (ADH) that binds to alpha-crystallin during chaperone-like action. The first method involved the incubation of alpha-crystallin with ADH peptides at 48 degrees C for 1 h followed by separation and analysis of bound peptides. In the second method, alpha-crystallin was first derivatized with a photoactive trifunctional cross-linker, sulfosuccinimidyl-2[6-(biotinamido)-2-(p-azidobenzamido)-hexanoamido]ethyl-1,3di-thiopropionate (sulfo-SBED), and then complexed with ADH at 48 degrees C for 1 h in the dark. The complex was photolyzed and digested with protease, and the biotinylated peptide fragments were isolated using an avidin column and then analyzed. The amino acid sequencing and mass spectral analysis revealed the sequence YSGVCHTDLHAWHGDWPLPVK (yeast ADH(40-60)) as the alpha-crystallin binding site in ADH. The interaction was further confirmed by demonstrating complex formation between alpha-crystallin and a synthetic peptide representing the binding site of ADH.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147351     DOI: 10.1016/s0167-4838(02)00356-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Identification of peptides in human Hsp20 and Hsp27 that possess molecular chaperone and anti-apoptotic activities.

Authors:  Rooban B Nahomi; Michael A DiMauro; Benlian Wang; Ram H Nagaraj
Journal:  Biochem J       Date:  2015-01-01       Impact factor: 3.857

Review 2.  A first line of stress defense: small heat shock proteins and their function in protein homeostasis.

Authors:  Martin Haslbeck; Elizabeth Vierling
Journal:  J Mol Biol       Date:  2015-02-10       Impact factor: 5.469

Review 3.  Therapeutic potential of α-crystallin.

Authors:  Ram H Nagaraj; Rooban B Nahomi; Niklaus H Mueller; Cibin T Raghavan; David A Ammar; J Mark Petrash
Journal:  Biochim Biophys Acta       Date:  2015-04-01

Review 4.  Alpha-crystallin-derived peptides as therapeutic chaperones.

Authors:  Murugesan Raju; Puttur Santhoshkumar; K Krishna Sharma
Journal:  Biochim Biophys Acta       Date:  2015-07-02

5.  Mapping protein interfaces by a trifunctional cross-linker combined with MALDI-TOF and ESI-FTICR mass spectrometry.

Authors:  Andrea Sinz; Stefan Kalkhof; Christian Ihling
Journal:  J Am Soc Mass Spectrom       Date:  2005-10-24       Impact factor: 3.109

6.  Conserved F84 and P86 residues in alphaB-crystallin are essential to effectively prevent the aggregation of substrate proteins.

Authors:  Puttur Santhoshkumar; K Krishna Sharma
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

7.  Identification of the rheumatoid arthritis shared epitope binding site on calreticulin.

Authors:  Song Ling; Andrew Cheng; Paul Pumpens; Marek Michalak; Joseph Holoshitz
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

8.  Small heat shock proteins sequester misfolding proteins in near-native conformation for cellular protection and efficient refolding.

Authors:  Sophia Ungelenk; Fatemeh Moayed; Chi-Ting Ho; Tomas Grousl; Annette Scharf; Alireza Mashaghi; Sander Tans; Matthias P Mayer; Axel Mogk; Bernd Bukau
Journal:  Nat Commun       Date:  2016-11-30       Impact factor: 14.919

9.  Anti-chaperone betaA3/A1(102-117) peptide interacting sites in human alphaB-crystallin.

Authors:  Guruprasad Rao; Puttur Santhoshkumar; K Krishna Sharma
Journal:  Mol Vis       Date:  2008-03-26       Impact factor: 2.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.